Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal abnormalities in acute lymphoblastic leukemia

C D Bloomfield, L L Lindquist, D Arthur

    Cancer Research
    |November 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A cluster-randomized trial of client and provider directed financial interventions to align incentives with appropriate case management in private medicine retailers: results of the TESTsmART Trial in Lagos, Nigeria.

    medRxiv : the preprint server for health sciences·2024
    Same author

    A cluster-randomized trial of client and provider-directed financial interventions to align incentives with appropriate case management in retail medicine outlets: results of the TESTsmART Trial in western Kenya.

    medRxiv : the preprint server for health sciences·2023
    Same author

    A pilot investigation on impact of participation in a long-term follow-up clinic (LTFU) on breast cancer and cardiovascular screening among women who received chest radiation for Hodgkin lymphoma.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2018
    Same author

    Chemical looping of metal nitride catalysts: low-pressure ammonia synthesis for energy storage.

    Chemical science·2017
    Same author

    No evidence for microsatellite instability in acute myeloid leukemia.

    Leukemia·2017
    Same author

    The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.

    Leukemia·2017

    Chromosome abnormalities are common in acute lymphoblastic leukemia (ALL). Specific translocations in non-T, non-B ALL are linked to shorter remission durations and can predict treatment response.

    Area of Science:

    • Hematology
    • Cytogenetics
    • Oncology

    Background:

    • Chromosome abnormalities are frequently observed in acute lymphoblastic leukemia (ALL).
    • Understanding these abnormalities is crucial for predicting patient outcomes.
    • Previous studies have suggested a link between specific chromosomal changes and ALL prognosis.

    Purpose of the Study:

    • To review the literature on chromosome abnormalities in ALL.
    • To analyze the clinical significance of these abnormalities in 60 patient cases.
    • To identify specific translocations associated with unique clinical findings and treatment responses in non-T, non-B ALL.

    Main Methods:

    • Literature review of chromosome abnormalities in acute lymphoblastic leukemia.
    • Analysis of 60 cases of ALL studied at the University of Minnesota.

    Related Experiment Videos

  • Correlation of specific chromosomal abnormalities, including translocations, with clinical and laboratory findings.
  • Main Results:

    • Nearly all ALL cases exhibit clonal chromosome abnormalities, predominantly hyperdiploid or pseudodiploid.
    • Four specific translocations (t(9;22), t(4;11), t(11;14), t(1;3)) are more frequent in non-T, non-B ALL.
    • Patients with pseudodiploid clones or translocations have significantly shorter first remissions.
    • Translocations in non-T, non-B ALL appear to differentiate poor responders from good responders.

    Conclusions:

    • The nature of chromosome abnormalities, particularly translocations, significantly impacts remission duration in ALL.
    • Specific translocations in non-T, non-B ALL are critical indicators of prognosis and treatment response.
    • Identifying these cytogenetic markers can aid in stratifying patients for tailored therapeutic strategies.